BURNABY, British Columbia – January 27, 2015 – LED Medical Diagnostics Inc. (“LED Medical” or the “Company”), announces that, subject to TSX Venture Exchange approval, it is undertaking a non-brokered private placement of up to 10,000,000 units at an issue price of CA$0.25 per unit for gross proceeds of up to $2.5 million. Each unit is comprised of one common share and one common share purchase warrant, with each warrant entitling the holder to acquire one common share at an exercise price of US$0.25 for a period of 24 months. All of the securities issued in connection with the private placement will be subject to a restricted period that expires four months after the issuance date. LED Medical may pay finders’ fees with respect to certain subscriptions in accordance with TSX Venture Exchange policies.
The proceeds will be used by LED Medical to support product development related to VELscope® Vx, to replenish imaging product inventory, including an initial stocking order related to the recent Canadian exclusive distribution agreement with Ray Co., a wholly owned subsidiary of Samsung Electronics, and for other working capital purposes.
About LED Medical Diagnostics Inc.
Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiary LED Dental, provides dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.
The Company is currently listed on the Toronto Stock Exchange (TSX-V) under the symbol “LMD”, the OTCQX under the symbol “LEDIF”, as well as the Frankfurt Stock Exchange under the symbol “LME”. For more information, call 844.952.7327 or visit www.leddental.com/investor-relations.